Liquefaction Liposuction Offers Faster Extraction and Less Downtime

TLL vs. SAL outcomes

A recent study published in the Aesthetic Surgery Journal (September 2018) revealed that tissue liquefaction liposuction (TLL, Hydrasolve, Andrew Technologies) extracts fat more quickly with less arm movement than traditional suction-assisted liposuction (SAL). TLL patients also experienced less bruising and swelling post treatment. Researchers Joseph P. Hunstad, MD, FACS, et al, performed a contralateral study with 31 adult female subjects.

Hong Kong Researchers Debut Novel Self-fitting Scaffold for Bone Regeneration

Researchers Debut Novel Self-Fitting Bone Scaffold

Hong Kong Polytechnic University (PolyU) announced that researchers, led by Professor Hu Jinlian (principal investigator), Dr Xie Ruiqi from the Institute of Textiles and Clothing, and Dr Guo Xia from its Department of Rehabilitation Sciences, have designed and fabricated a self-fitting bone scaffold that can be safely implanted into bone defects and induce bone regeneration. The scaffold is made of a shape memory polyurethane foam and hydroxyapatite (HA) nano-particles. The team collaborated with Sichuan University in cell culture and animal modeling for the research.

Cynosure To Distribute Nitrous Oxide and Oxygen System in Aesthetics Market

Cynosure enters into agreement with Parker Hannifin

Hologic’s Cynosure division has entered into an agreement with Porter Instrument, a business unit of Parker Hannifin Corporation, for distribution rights in the United States and Canada to Porter’s Nitronox nitrous oxide and oxygen system. Nitronox is a self-administered nitrous oxide and oxygen delivery system providing a fast-acting inhaled analgesic that helps patients manage potential discomfort and anxiety while remaining alert and conscious during their aesthetic procedures.

Bonti Announces Results of Phase 2a Scar Reduction Clinical Study

EB-001A Clinical Trial Results

Bonti, a privately held, clinical-stage biotechnology company, announced topline results of its SHINE-1 (Scar Healing Improvement with Neurotoxin E) Phase 2a clinical trial, which evaluated the company’s EB-001A for scar reduction following Mohs surgery. EB-001, the active ingredient in EB-001A, is a novel botulinum neurotoxin serotype E (BoNT/E) with a unique clinical profile, characterized by a faster onset of action (within 24 hours) and a shorter duration of activity (two to four weeks) compared to botulinum neurotoxin serotype A (BoNT/A) products.

Merz Creates Americas Region and Expands Rhatigan’s Role

Merz Launches Americas Division

Bob Rhatigan, CEO of Merz North America, has been appointed to a new position in the company, president and CEO of Merz-Americas effective September 1. This expands Rhatigan’s leadership of Merz’s North American business as he assumes responsibility for Latin America and will oversee the overall commercial strategy for the company’s newly created “Americas Region.” In addition, Frank Brandt-Pollmann has been promoted to area vice president, Latin America. He will lead Merz’s business operations across Latin America and report directly to Rhatigan.

RealSelf Appoints First Chief Medical Officer

RealSelf Appoints Chief Medical Officer

New York-based Plastic and Reconstructive Surgeon Lara Devgan, MD, has joined RealSelf as the company’s first chief medical officer. She will act as senior medical advisor and spokesperson for the company, reporting to RealSelf CEO and Founder Tom Seery. Dr. Devgan will dedicate a portion of her time to RealSelf as a spokesperson and as counsel on services and practices to further support the company’s mission to help consumers make more confident decisions and connect them with the right medical professionals.

Ortho Dermatologics Announces Aspire Scholarship Recipients

Ortho Dermatologics, a division of Bausch Health Companies, has announced the 2018 honorees of its Aspire Higher program, which since 2013 has granted more than $450,000 in scholarships to students who have been affected by dermatologic conditions. This year nine students will receive scholarships of $10,000 each to pursue graduate or undergraduate degrees at an accredited, nonprofit, two- or four-year college, university, or advanced (post-high school) vocational or technical school.

Addressing the FDA Warning on Vaginal Rejuvenation Devices

Addressing patient concerns about energy-based vaginal treatments

On July 30, U.S. Food and Drug Administration Commissioner Scott Gottlieb, MD, released a statement concerning devices marketed for “vaginal rejuvenation.” He noted that, although the FDA has cleared or approved laser and energy-based devices for indications including the destruction of abnormal or pre-cancerous cervical or vaginal tissue, as well as condylomas (genital warts), none of these devices have been evaluated or confirmed by the FDA for “vaginal rejuvenation.”

ASAPS Launches Task Force To Research Brazilian Buttock Lift Complications

Recommendations for Patient Safety in Gluteal Augmentation

Recent deaths and serious complications associated with the increasingly popular Brazilian Buttock Lift Procedure (BBL) have prompted the American Society for Aesthetic Plastic Surgery (ASAPS) to form a task force to examine the causes behind these complications and help educate physicians on best practices.

The ASAPS notes that to-date, autopsy reports reveal that all deceased BBL patients have had specific findings in common, including: